Literature DB >> 26622657

Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.

Lin Ye1, Yongning Jia2, K E Ji1, Andrew J Sanders1, Kan Xue3, Jiafu Ji3, Malcolm D Mason4, Wen G Jiang1.   

Abstract

Traditional Chinese medicine (TCM) has been a major part of healthcare in China, and has extensively affected medicine and healthcare in surrounding countries over a long period of time. In the fight against cancer, certain anticancer remedies using herbs or herbal formulas derived from TCM have been developed for the management of malignancies. Furthermore, there are clinical trials registered for the use of herbal remedies in cancer management. Herbal medicine has been used as part of combined therapies to reduce the side-effects of chemotherapy, including bone marrow suppression, nausea and vomiting. Herbal remedies have also been used as chemopreventive therapies to treat precancerous conditions in order to reduce the incidence of cancer in high-risk populations. Emerging evidence has revealed that herbal remedies can regulate the proliferation, apoptosis, adhesion and migration of cancer cells. In addition to this direct effect upon cancer cells, a number of herbal remedies have been identified to suppress angiogenesis and therefore reduce tumour growth. The inhibition of tumour growth may also be due to modifications of the host immune system by the herbal treatment. However, the precise mechanisms underlying the therapeutic effects of herbal remedies remain poorly understood and are yet to be fully elucidated. The present study aims to summarize the current literature and clinical trial results of herbal remedies for cancer treatment, with a particular focus on the recent findings and development of the Yangzheng Xiaoji capsule.

Entities:  

Keywords:  cancer; metastasis; therapy; traditional Chinese medicine

Year:  2015        PMID: 26622657      PMCID: PMC4533180          DOI: 10.3892/ol.2015.3459

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  99 in total

Review 1.  Cancer chemoprevention with garlic and its constituents.

Authors:  Yogeshwer Shukla; Neetu Kalra
Journal:  Cancer Lett       Date:  2006-06-21       Impact factor: 8.679

2.  Induction of apoptosis by diallyl sulfide in DMBA-induced mouse skin tumors.

Authors:  Annu Arora; Yogeshwer Shukla
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

3.  Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis.

Authors:  Kun Zhu; Ichio Fukasawa; Makiko Furuno; Fujiyuki Inaba; Tatsuo Yamazaki; Tetsu Kamemori; Nobuaki Kousaka; Yoriko Ota; Masatoshi Hayashi; Toshiyuki Maehama; Noriyuki Inaba
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

4.  Antitumor-promoting activity of garlic extracts.

Authors:  H Nishino; A Iwashima; Y Itakura; H Matsuura; T Fuwa
Journal:  Oncology       Date:  1989       Impact factor: 2.935

5.  Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity.

Authors:  Koji Ochiai; Satoshi Takita; Tomohiko Eiraku; Akihiko Kojima; Kazuhiko Iwase; Tetsuya Kishi; Kazunori Fukuchi; Tokutaro Yasue; David R Adams; Robert W Allcock; Zhong Jiang; Yasushi Kohno
Journal:  Bioorg Med Chem       Date:  2012-01-28       Impact factor: 3.641

6.  Field population-based blocking treatment of esophageal epithelia dysplasia.

Authors:  Jun Hou; Pei-Zhong Lin; Zhi-Feng Chen; Zhen-Wei Ding; Shao-Sheng Li; Fan-Shu Men; Li-Ping Guo; Yu-Tong He; Chui-Yun Qiao; Chui-Lan Guo; Jian-Ping Duan; Deng-Gui Wen
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

7.  Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc 25 C.

Authors:  Dong Xiao; Anna Herman-Antosiewicz; Jedrzej Antosiewicz; Hui Xiao; Marni Brisson; John S Lazo; Shivendra V Singh
Journal:  Oncogene       Date:  2005-09-15       Impact factor: 9.867

Review 8.  A Kampo medicine "Juzen-taiho-to"--prevention of malignant progression and metastasis of tumor cells and the mechanism of action.

Authors:  I Saiki
Journal:  Biol Pharm Bull       Date:  2000-06       Impact factor: 2.233

9.  A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.

Authors:  Alejandra T Perez; Banu Arun; Debu Tripathy; Mary A Tagliaferri; Heather S Shaw; Gretchen G Kimmick; Isaac Cohen; Emma Shtivelman; Katherine A Caygill; Deborah Grady; Mark Schactman; Charles L Shapiro
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

10.  Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling.

Authors:  Sang-Hun Kang; Soo-Jin Jeong; Sun-Hee Kim; Ji-Hyun Kim; Ji Hoon Jung; Wonil Koh; Jung Hyo Kim; Dae Keun Kim; Chang-Yan Chen; Sung-Hoon Kim
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

View more
  38 in total

1.  Anti-proliferative and pro-apoptotic effects of rosemary and constituent terpenoids in a model for the HER-2-enriched molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

2.  Inhibitory effects of Chinese nutritional herbs in isogenic breast carcinoma cells with modulated estrogen receptor function.

Authors:  Nitin Telang; Guo Li; Meena Katdare; Daniel Sepkovic; Leon Bradlow; George Wong
Journal:  Oncol Lett       Date:  2016-09-28       Impact factor: 2.967

3.  Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Biomed Rep       Date:  2017-08-01

4.  Identification of Triptophenolide from Tripterygium wilfordii as a Pan-antagonist of Androgen Receptor.

Authors:  Yang He; Meng Wu; Yangguang Liu; Quanjie Li; Xiaoyu Li; Laixing Hu; Shan Cen; Jinming Zhou
Journal:  ACS Med Chem Lett       Date:  2016-09-28       Impact factor: 4.345

5.  The nutritional herb Epimedium grandiflorum inhibits the growth in a model for the Luminal A molecular subtype of breast cancer.

Authors:  Nitin T Telang; Gou Li; Meena Katdare; Daniel W Sepkovic; H Leon Bradlow; George Y C Wong
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

Review 6.  Stem Cell Models for Cancer Therapy.

Authors:  Nitin Telang
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 7.  Advances in Research on Anticancer Properties of Salidroside.

Authors:  An-Qi Sun; Xiu-Lian Ju
Journal:  Chin J Integr Med       Date:  2020-03-06       Impact factor: 1.978

8.  Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells.

Authors:  Binbing Ling; Deborah Michel; Meena Kishore Sakharkar; Jian Yang
Journal:  Drug Des Devel Ther       Date:  2016-11-01       Impact factor: 4.162

Review 9.  Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery.

Authors:  Qiang Sun; Man He; Meng Zhang; Sha Zeng; Li Chen; Hui Zhao; Han Yang; Maolun Liu; Shan Ren; Haibo Xu
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

10.  Cinnamomum verum component 2-methoxycinnamaldehyde: a novel antiproliferative drug inducing cell death through targeting both topoisomerase I and II in human colorectal adenocarcinoma COLO 205 cells.

Authors:  Kuen-Daw Tsai; Jonathan Cherng; Yi-Heng Liu; Ta-Wei Chen; Ho-Yiu Wong; Shu-Mei Yang; Kuo-Shen Chou; Jaw-Ming Cherng
Journal:  Food Nutr Res       Date:  2016-06-07       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.